Please login to the form below

Not currently logged in
Email:
Password:

Aeterna Zentaris looks to Boehringer for science head

Richard Sachse joins Canadian firm as chief scientific officer
Aeterna Zenaris Richard Sachse

Aeterna Zentaris has appointed Boehringer Ingelheim's Dr Richard Sachse as senior VP and chief scientific officer.

Dr Sachse was most recently head of global translational medicine at Germany-based Boehringer following several roles at major pharma companies in Europe, including Bayer, Schwarz Pharma and UCB.

He will now make the move to Canada to take on his role at Aeterna Zentaris, which specialises in oncology and endocrinology.

The company's president and CEO David Dodd outline Dr Sachse's new role: “As CSO, he will be responsible for all areas of our global research and development activities, while also serving on the corporate operating committee.”

Dr Sachse said he was “delighted” by the opportunity his new position offered him.

He said: “I believe that the combination of Aeterna Zentaris' highly qualified and motivated personnel, together with its strong scientific platform, holds much promise for the future success of our projects."

8th January 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics